VF
ARRY

Virtu Financial’s Array Biopharma Inc ARRY Stock Holding History

Virtu Financial’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,199
Closed -$200K – 2076
2019
Q1 		$200K Sell
8,199
-2,229
-21% -$46.4K 0.01% 1013
2018
Q4 		$149K Sell
10,428
-635
-6% -$9.63K 0.01% 1040
2018
Q3 		$168K Sell
11,063
-36,281
-77% -$556K 0.01% 1115
2018
Q2 		$794K Buy
+47,344
New +$753K 0.05% 535
2017
Q4 		– Sell
-27,595
Closed -$339K – 3294
2017
Q3 		$339K Buy
+27,595
New +$256K 0.02% 1270

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial's ARRY Position: Q2 2019 in Review

Virtu Financial sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 8,199 shares — an estimated $200K sold.

Virtu Financial first reported a position in ARRY in Q3 2017 and held it in 5 quarters. The position peaked at $794K in Q2 2018. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Virtu Financial reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Virtu Financial sold 8,199 Array Biopharma Inc shares in Q2 2019, an estimated $200K.
  • Virtu Financial first reported a position in Array Biopharma Inc in Q3 2017 and held it in 5 quarters.
  • Virtu Financial's Array Biopharma Inc position peaked at $794K in Q2 2018.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.